<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/212</identifier>
				<datestamp>2024-10-30T19:15:45Z</datestamp>
				<setSpec>aavptbiennial:S6</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Interferon: An Application of Recombinant DNA Technology in Bovine Respiratory Disease</dc:title>
	<dc:creator xml:lang="en">Babiuk, L. A.</dc:creator>
	<dc:creator xml:lang="en">Lawman, M. J. P.</dc:creator>
	<dc:creator xml:lang="en">Gifford, G. A.</dc:creator>
	<dc:creator xml:lang="en">Bielefeldt Ohmann, H.</dc:creator>
	<dc:subject xml:lang="en">bovine interferon</dc:subject>
	<dc:subject xml:lang="en">bovine herpesvirus</dc:subject>
	<dc:subject xml:lang="en">leukocyte function</dc:subject>
	<dc:subject xml:lang="en">prophylaxis</dc:subject>
	<dc:subject xml:lang="en">bovine respiratory disease</dc:subject>
	<dc:description xml:lang="en">Intranasal or intramuscular treatment of calves with recombinant bovine interferon prior to challenge with bovine herpesvirus-1/ P. haemolytica reduced clinical signs, number of days animals were considered to be sick, serum parameters indicative of disease (fibrinogen), lung lesions and leukocyte functions. Although clinical signs were dramatically reduced, the level of virus shedding in nasal secretions were not reduced. These results, combined with the observation that bovine herpesvirus-1 is relatively resistent to the direct antiviral effects of bovine alpha 1, interferon suggests that bovine interferon may have a greater immunomodulatory role in this disease complex than a direct antiviral effect. This is further supported by the observation that interferon did have the capability of altering leukocyte function in vivo and in vitro. The potential value of using interferon as a method of prophylaxis in bovine respiratory disease under feedlot conditions is discussed.</dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>1986-06-10</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/212</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; Fifth Biennial Symposium; 236-254</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/212/200</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1986 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
